News

Subscribe to our mailing list to receive research, advocacy and other updates from MS Australia

Categories
Categories
date range
date range

MS Australia News

4 November 2024

Results from the D-Lay MS study, presented at ECTRIMS 2024, appeared to offer contrasting findings to PrevANZ, yet both reinforce the shared message that vitamin D, while potentially beneficial for…

30 October 2024

CEO Rohan Greenland asks whether the Australian Government is doing enough to support MS research and neurological research more generally….

29 October 2024

Researchers explore how an evidence-based, co-designed, digital nutrition education program empowers people with MS to make positive changes to their diet….

29 October 2024

As bushfire and heatwave season approaches, MS Australia-supported researchers, in partnership with Australian Red Cross, have created new crisis plan resources to help the MS community prepare for emergencies using…

29 October 2024

The prevalence of MS is increasing in Australia nationally as well as in individual states and territories. This has implications for the resources needed to prevent, treat and manage MS….

24 September 2024

CEO Rohan Greenland discusses the announcement of a new Aged Care Bill, which has many welcome changes for people living with disability and includes a long overdue ‘statement of rights’…

24 September 2024

Researchers supported by MS Australia have found that low intensity repetitive transcranial magnetic stimulation enhances myelin repair in preclinical models of MS….

24 September 2024

Survey highlights Australian expertise and training priorities in delivering telehealth exercise for MS….

24 September 2024

In Australia’s first study into crisis planning for people living with MS, researchers found only a small proportion had a crisis plan that met their needs….

24 September 2024

At 70, Wayne feels grateful for his thriving business, good health and loving family. In honour of a family friend who has MS, he decided to support MS research beyond…

5 September 2024

This Women’s Health Week in Australia, MS Australia highlights the unique challenges faced by three women living with multiple sclerosis….

5 September 2024

A phase 3 clinical trial of the BTK inhibitor, tolebrutinib, has shown a reduction in disability accumulation in people with non-relapsing secondary progressive MS….

Newsletter subscription

  • Enter your details

Vitamin D and MS – Insights from Recent Research